HGS Stock Dips After It Ends Hepatitis C Test
158244
Human Genome Sciences' stock price plunged more than 40 percent yesterday, after the company announced it would abandon higher-dose tests of its hepatitis C drug because an independent monitoring group expressed concerns about lung-related side effects.
624206
Shares of drug distributor Henry Schein Inc. (HSIC.O: Quote, Profile, Research) fell nearly 3 percent before the bell on Wednesday after trading resumed a day after news that a
686772
Merck &amp; Co. shares fell as much as 7 percent to their lowest level in more than eight years after the Wall Street Journal said the drugmaker tried for years to stop safety concerns from hurting sales of its Vioxx painkiller.
218084
European stocks including Bayer AG and LVMH Moet Hennessy Louis Vuitton SA may fall after their U.S. traded securities declined following the close of exchanges in Europe.
685306
Merck &amp; Co. Inc. (MRK.N: Quote, Profile, Research) , reeling from the recent withdrawal of its Vioxx arthritis drug, on Wednesday said 2005 earnings will decline to
458972
A sign that your stock's run is done.
672313
The Nikkei average dipped 0.37 percent by the close on Wednesday as some major banks, including UFJ Holdings Inc., reversed gains made after Japan&#39;s state turnaround body approved
189160
Shares of Merck &amp; Co. plunged Monday after a news report suggested that the company knew about risks associated with its recently recalled Vioxx arthritis medication and tried to cover them up.
647552
U.S. stocks ended sharply lower on Friday, with all three major indexes snapping a three-week streak of gains, after disappointing results from companies such as Caterpillar Inc.  and Google . Concerns about more credit problems tied to the subprime mortgage market added to the weaker sentiment.
122895
Drug stocks across the board fell amid renewed safety concerns over a class of blockbuster drugs used to treat arthritis. Preprint articles published on the New England Journal of Medicine&#39;s Web site Wednesday
563836
Biopharmaceutical company Gilead Sciences Inc. reported Tuesday that clinical data on its hepatitis B treatment Hepsera showed that the drug reduced the virus to undetectable levels in more than half the patients on the drug after more than two years.
380561
Shares of Merck &amp; Co. plunged almost 10 percent yesterday after a media report said that documents show the pharmaceutical giant hid or denied
677746
NEW YORK - Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market...
196745
Wall Street stock indexes closed out a dismal third quarter mixed Thursday after Merck &amp; Co. stated it would remove its best-selling Vioxx arthritis drug from the market.
390028
NEW YORK  -The Dow and the S&P recovered from their earlier drops to trade flat, after U.N. officials said there was no danger from vials of chemicals found in a locked box in a United Nations building in New York.
577581
Stocks fell after building materials maker USG Corp.  raised concerns about the housing slump, while chemical company DuPont Co.  put a damper on the earnings reporting season with results that missed estimates.
163351
MedImmune's shares sank nearly 9 percent yesterday after the company reported weaker-than-expected fourth-quarter revenue for two high-profile products and disclosed a delay in filing for federal approval of a new version of Synagis, its lead drug.